Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Outcome of Allotment Committee Meeting

 Sun Pharmaceutical Industries Ltd has informed BSE that the Allotment Committee of Directors at its meeting held on November 22, 2016, allotted 16,229 (Sixteen Thousand Two Hundred and Twenty Nine) equity shares of the Company of Re. 1/- (Rupee One Only) each, on exercise of stock options under the Sun Employee Stock Option Scheme - 2015.Accordingly, post the above allotment the paid-up equity share capital of the Company is Rs. 2,39,92,70,188/-...
22-11-2016
Bigul

Sun Pharma: Bright prospects

 Integration of Ranbaxy's operations and clearance of Halol facility should pay off
20-11-2016
Bigul

ICMR, Govt of MP and FDEC-India sign tri-party agreement to launch Malaria Free India demonstration project in Mandla district of Madhya Pradesh

 Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated November 15, 2016 titled "ICMR, Govt of MP and FDEC-India sign tri-party agreement to launch Malaria Free India demonstration project in Mandla district of Madhya Pradesh".
15-11-2016

Sun Pharma Q2 profit rises to Rs2,235 crore, beats estimates

 Sun Pharma sales the US, its largest market, rises to 9%, while in India 11%
10-11-2016
Bigul

Results Press Release for September 30, 2016

 Sun Pharmaceutical Industries Ltd has informed BSE about : 1. Result Press Release for the period ended September 30, 2016
10-11-2016
Bigul

Outcome of Board Meeting

 Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 10, 2016, has approved subject to receipt of further approvals of the honble High Court of Gujarat or the National Company Law Tribunal (High Court), as the case may be, Stock Exchanges, Securities and Exchange Board of India and all other requisite parties/authorities, the Scheme of Arrangement for amalgamation of Sun...
10-11-2016
Bigul

Announces Q2 Results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated) for the Quarter ended September 30, 2016

 Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended September 30, 2016The Unaudited Standalone results for the Quarter ended September 30, 2016 The Company has posted a net profit of Rs. 1845.40 million for the quarter ended September 30, 2016 as compared to net loss of Rs. (6002.30) million for the quarter ended September 30, 2015. Total Income has increased from Rs. 18889.40 million for the...
10-11-2016
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 Raksha S Valia has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
09-11-2016
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 Kumud Shantilal Shanghvi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
04-11-2016

Pharma stocks fall over possible US probe into price cartalization

 Shares of Sun Pharmaceuticals Industries Ltd fell 7.1%, its steepest fall since 21 December 2015 and hit a low of Rs 654.70 a sharea level last seen on 27 June 2014
04-11-2016
Next Page
Close

Let's Open Free Demat Account